Manulife (Manufacturers Life Insurance)
XLRN

Manulife (Manufacturers Life Insurance)’s Acceleron Pharma XLRN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-28,640
Closed -$2.57M – 2977
2020
Q1 		$2.57M Buy
28,640
+1,357
+5% +$105K ﹤0.01% 1240
2019
Q4 		$1.45M Sell
27,283
-888
-3% -$40.5K ﹤0.01% 1518
2019
Q3 		$1.14M Sell
28,171
-56
-0.2% -$2.43K ﹤0.01% 1582
2019
Q2 		$1.16M Sell
28,227
-427
-1% -$17.7K ﹤0.01% 1573
2019
Q1 		$1.33M Buy
28,654
+4,752
+20% +$209K ﹤0.01% 1553
2018
Q4 		$1.04M Sell
23,902
-1,488
-6% -$74.3K ﹤0.01% 1574
2018
Q3 		$1.45M Sell
25,390
-3,800
-13% -$187K ﹤0.01% 1580
2018
Q2 		$1.42M Buy
29,190
+973
+3% +$35.5K ﹤0.01% 1657
2018
Q1 		$1.1M Sell
28,217
-773
-3% -$32.9K ﹤0.01% 1778
2017
Q4 		$1.23M Buy
28,990
+4,381
+18% +$164K ﹤0.01% 1730
2017
Q3 		$919K Sell
24,609
-595
-2% -$20.7K ﹤0.01% 1850
2017
Q2 		$767K Buy
25,204
+3,301
+15% +$95.7K ﹤0.01% 1979
2017
Q1 		$580K Buy
21,903
+2,562
+13% +$67.5K ﹤0.01% 2077
2016
Q4 		$494K Buy
19,341
+179
+0.9% +$5.67K ﹤0.01% 2102
2016
Q3 		$693K Buy
19,162
+80
+0.4% +$2.65K ﹤0.01% 1863
2016
Q2 		$648K Buy
19,082
+3,613
+23% +$117K ﹤0.01% 1872
2016
Q1 		$398K Buy
15,469
+626
+4% +$18.2K ﹤0.01% 2118
2015
Q4 		$724 Buy
14,843
+131
+0.9% +$4.71K ﹤0.01% 1791
2015
Q3 		$367 Buy
14,712
+316
+2% +$9.5K ﹤0.01% 2200
2015
Q2 		$455 Buy
14,396
+3,302
+30% +$107K ﹤0.01% 2191
2015
Q1 		$423 Buy
11,094
+253
+2% +$10.1K ﹤0.01% 2188
2014
Q4 		$422 Sell
10,841
-352
-3% -$12.3K ﹤0.01% 2099
2014
Q3 		$338 Buy
11,193
+190
+2% +$5.35K ﹤0.01% 2258
2014
Q2 		$374K Sell
11,003
-61,580
-85% -$2.06M ﹤0.01% 2261
2014
Q1 		$2.5K Buy
72,583
+72,420
+44,429% +$3.27M ﹤0.01% 1265
2013
Q4 		$6 Buy
+163
New +$3.93K ﹤0.01% 3492

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s XLRN Position: Q2 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Acceleron Pharma (XLRN) in Q2 2020, closing a stake of 28,640 shares — an estimated $2.57M sold.

Manulife (Manufacturers Life Insurance) first reported a position in XLRN in Q4 2013 and held it in 26 quarters. The position peaked at $2.57M in Q1 2020. 242 funds tracked by Wall St. Rank hold XLRN as of Q2 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Acceleron Pharma position as of Q2 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 28,640 Acceleron Pharma shares in Q2 2020, an estimated $2.57M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Acceleron Pharma in Q4 2013 and held it in 26 quarters.
  • Manulife (Manufacturers Life Insurance)'s Acceleron Pharma position peaked at $2.57M in Q1 2020.
  • 242 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2020, filed 10 Aug 2020.